Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
Therapeutics Medicine & Life Sciences
Chronic Hepatitis C Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Ribavirin Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences
Genotype Medicine & Life Sciences
Liver Medicine & Life Sciences
Interferons Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1999 2020

Research Output 1989 2017

2 Citations

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: Results of the real-world, clinical practice HCV-TARGET study

Welzel, T. M., Nelson, D. R., Morelli, G., Di Bisceglie, A., Reddy, R. K., Kuo, A., Lim, J. K., Darling, J., Pockros, P., Galati, J. S., Frazier, L. M., Alqahtani, S., Sulkowski, M. S., Vainorius, M., Akushevich, L., Fried, M. W. & Zeuzem, S. Oct 1 2017 In : Gut. 66, 10, p. 1844-1852 9 p.

Research output: Research - peer-reviewArticle

Ribavirin
Genotype
Safety
Infection
Therapeutics
3 Citations

Ledipasvir–sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders

Walsh, C. E., Workowski, K., Terrault, N. A., Sax, P. E., Cohen, A., Bowlus, C. L., Kim, A. Y., Hyland, R. H., Han, B., Wang, J., Stamm, L. M., Brainard, D. M., McHutchison, J. G., von Drygalski, A., Rhame, F., Fried, M. W., Kouides, P., Balba, G. & Reddy, K. R. Mar 1 2017 In : Haemophilia. 23, 2, p. 198-206 9 p.

Research output: Research - peer-reviewArticle

Ribavirin
Chronic Hepatitis C
Hemorrhage
sofosbuvir drug combination ledipasvir
Sofosbuvir
2 Citations

HCV Council - critical appraisal of data: Recommendations for clinical practice in a rapidly evolving therapeutic landscape

Reau, N., Fried, M. W., Nelson, D. R., Brown, R. S., Everson, G. T., Gordon, S. C., Jacobson, I. M., Lim, J. K., Pockros, P. J., Reddy, K. R. & Sherman, K. E. Apr 1 2016 In : Liver International. 36, 4, p. 488-502 15 p.

Research output: Research - peer-reviewArticle

Hepacivirus
Therapeutics
Expert Testimony
Chronic Hepatitis C
Hepatitis C

High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity

Johansson, S., Talloen, W., Tuefferd, M., Darling, J., Fanning, G., Fried, M. W. & Aerssens, J. Mar 1 2016 In : Liver International. 36, 3, p. 344-352 9 p.

Research output: Research - peer-reviewArticle

Ribavirin
Hepacivirus
Genotype
Therapeutics
Chemokines
48 Citations

Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network

Brown, R. S., O'Leary, J. G., Reddy, K. R., Kuo, A., Morelli, G. J., Burton, J. R., Stravitz, R. T., Durand, C., Di Bisceglie, A. M., Kwo, P., Frenette, C. T., Stewart, T. G., Nelson, D. R., Fried, M. W. & Terrault, N. A. Jan 1 2016 In : Liver Transplantation. 22, 1, p. 24-33 10 p.

Research output: Research - peer-reviewArticle

Therapeutic Human Experimentation
Hepatitis C
Interferons
Registries
Genotype